Induction of EGFP expression by Ar ovaries in Ar mice was apparent in the uterus and pituitary gland, as examined under fluorescence stereomicroscope Fig
tamoxifen pct Secondary endpoints were i change in risk biomarkers including cytomorphology categorical descriptor and index score, Ki 67, mammographic breast density, serum fasting insulin and pro insulin, assessments of insulin resistance sensitivity, IGFI IGFBP3, adiponectin and leptin and their ratio, BMI, change in body fat, body fat distribution, and lean body mass; ii change in fatty acid composition primarily in erythrocyte and breast tissue phospholipid compartments; iii change in molecular mechanism of action biomarkers including targeted mRNAs, chemokines, and peptides; and iv adverse events and quality of life indices
